Physician profile
Michael J Phillips
NPI 1881884872
$2,147.58
in general payments reported to CMS, 2019-2025
15 companies · $484 in 2025
The $484 reported for 2025 was more than what 76% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $576 · 2021: $405 · 2022: $278 · 2023: $268 · 2024: $136 · 2025: $484.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $674 · Entertainment: $214.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $674.34 |
| Entertainment | $214.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $813.09 | 2019-2025 | Acuvue |
| Alcon Vision LLC | $635.97 | 2019-2025 | Precision 1, Precision7, Total30 |
| Optos, INC. | $214.22 | 2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Heidelberg Engineering, INC. | $105.63 | 2021 | |
| Johnson & Johnson Surgical Vision, INC. | $90.67 | 2025 | Tecnis Simplicity |
| Bausch & Lomb Americas INC. | $55.41 | 2022-2025 | Infuse |
| Coopervision INC. | $46.26 | 2025 | Clariti Contact Lens |
| Tarsus Pharmaceuticals, INC. | $39.36 | 2024 | Xdemvy |
| Regeneron Healthcare Solutions, INC. | $32.09 | 2025 | Dupixent |
| Maculogix, INC. | $30.85 | 2019 | |
| Abbvie INC. | $25.94 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $16.12 | 2021 | |
| Glaukos Corporation | $14.86 | 2022 | |
| Kala Pharmaceuticals, INC. | $13.65 | 2021 | |
| Allergan, INC. | $13.46 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Phillips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.